Highly-accurate metabolomic detection of early-stage ovarian cancer

Sci Rep. 2015 Nov 17:5:16351. doi: 10.1038/srep16351.

Abstract

High performance mass spectrometry was employed to interrogate the serum metabolome of early-stage ovarian cancer (OC) patients and age-matched control women. The resulting spectral features were used to establish a linear support vector machine (SVM) model of sixteen diagnostic metabolites that are able to identify early-stage OC with 100% accuracy in our patient cohort. The results provide evidence for the importance of lipid and fatty acid metabolism in OC and serve as the foundation of a clinically significant diagnostic test.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood*
  • CA-125 Antigen / blood
  • Case-Control Studies
  • Chromatography, High Pressure Liquid
  • Early Detection of Cancer / standards*
  • Female
  • Humans
  • Lysophospholipids / blood
  • Metabolome
  • Metabolomics*
  • Middle Aged
  • Ovarian Neoplasms / blood*
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology*
  • Principal Component Analysis
  • Sensitivity and Specificity
  • Support Vector Machine
  • Tandem Mass Spectrometry

Substances

  • Biomarkers, Tumor
  • CA-125 Antigen
  • Lysophospholipids
  • lysophosphatidylethanolamine
  • lysophosphatidylinositol